| AFFECTIVE DOMAIN
A--------------> |
COGNITIVE DOMAIN
B---------------> |
SENSORIMOTOR DOMAIN
C |
|
| (FUNCTION) | (STRUCTURE) | (EFFECT) | |
| LEVEL
III ASSESSMENT (PRESUPPOSITIONS & STANDARDS) |
ASSESSMENT OF CLINICAL TREATMENT & RESEARCH
----------------------------- ----------------------------- -----------------------------
9 |
ARE HYPOTHETICAL CONSTRUCTS NECESSARY?
(major issue) ----------------------------- NATIONAL RESEARCH EFFORTS ----------------------------- TYPES OF RESEARCH STUDIES ----------------------------- 8 |
CURE (when?)
----------------------------- MONITORING RESEARCH ---------------------------- MISTAKES & FAILURE OF RESEARCH ----------------------------- 7 |
| LEVEL
II THEORY (IMPLICATIONS) |
OPPOSITIONAL RESPONSES
----------------------------- REFUSALS ---------------------------- ANXIETY ----------------------------- SETTING ----------------------------- -----------------------------
6 |
APPLIED BEHAVIOR ANALYSIS
----------------------------- S-R THEORY ----------------------------- COGNITIVE BEHAVIOR APPROACH ----------------------------- HYPOTHETICAL CONSTRUCTS ----------------------------- TRIPLE MODE RESPONSE ASSESSMENT ----------------------------- 5 |
TREATMENT LITERATURE
----------------------------- EXAMINATION OF STUDIES ----------------------------- KAZDEN ----------------------------- BANDURA ----------------------------- 4 |
| LEVEL
I PRACTICE |
FEAR & PHOBIA
----------------------------- DEVELOPMENTAL FORCE ----------------------------- DESENSITIZATION PROCESS ----------------------------- (TRIGGER STIMULI) ----------------------------- -----------------------------
3 |
INTERVENTION
METHODS ----------------------------- TREATMENT ----------------------------- SYSTEMATIC DESENSITIZATION ---------------------------- ------------------------------ -------------------------------
2 |
BEHAVIOR DISORDER
----------------------------- PROBLEMATIC BEHAVIORS ----------------------------- OBSERVED TREATMENT EFFECTS ----------------------------- FEAR RESPONSE ----------------------------- MEASURES ---------------------------- APPROACH BEHAVIOR ----------------------------- 1 |
| A-----------> | B-----------------> | C | |
| Research goals | research strategies | research results | |
| III
ASSESSMENT |
CLIENT COMFORT DURING INVESTIGATION
NORMATIVE DATA USED AS CRITERIA FOR JUDGMENT OF OUTCOME LEVEL CONCERN FOR EFFICIENCY & COST RELATED MATTERS
|
CLINICALLY REFERENCED CRITERIA
SOCIAL VALIDATION CRITERIA (WOLFF) NORMATIVE DATA USED AS CRITERIA FOR JUDGMENT OF OUTCOME LEVEL CLIENT RELATED CRITERIA COST ANALYSIS EVALUATIONS REVISIONS IN TREATMENT |
JUDGMENT OF HOW WELL CONTROLLED A STUDY WAS
TREATMENT SUCCESS & EFFICIENCY SIGNIFICANCE LEVEL DECISIONS OUTCOME LEVEL SATISFACTION WITH ADEQUACY OF DEPENDENT MEASURES RELATED TO OUTCOME |
| II
THEORY |
SUPPORT OF A STANDARDIZED TREATMENT APPROACH TO OBTAIN CLINICAL RESEARCH
DATA
GENERALIZED EFFECTS TREATED AS GOAL OF TREATMENT |
(single VS. group)
CASE STUDY INVESTIGATIONS REPLICATION STUDIES TIME SERIES DESIGNS DEVIANT CASE ANALYSIS OR TRACER APPROACH |
THERAPEUTIC PROGRAM
INFERENCE DRAWN FROM CASE STUDY DESENSITIZATION HIERARCHY GENERALIZED EFFECTS OF TREATMENT ACROSS SETTINGS |
| I
PRACTICE |
NEED FOR FOLLOW UP DATA
|
OBSERVATIONAL & STANDARDIZED METHODS OF DATA GATHERING
OBJECTIVE MEASURES INFORMATION DATA FOR COST ANALYSIS ASSESSMENT (FAMILY) STRESS, TIME FOR IMPLEMENTATION, NEGATIVE SIDE EFFECTS, ETC.) |
INCIDENCE OF SYMPTOMS & FOLLOW UP
--------------------- CHRONIC PROBLEM MONITORED DEPENDENT VARIATION MONITORED INDEPENDENT (TREATMENT) VARIATION ------------------- TARGET BEHAVIORS ---------------------- FOLLOW UP MEASURES |
|
|
|
|